SCHEMBL23729624

SCHEMBL23729624

CCC(=O)CCCCCCCCCC(=O)N(C)CC(C)C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 3/20 0.39
▸ PHF8 Q9UPP1 2/20 0.39
▸ KDM4A O75164 1/20 0.39
▸ KDM2A Q9Y2K7 1/20 0.39
▸ EPHX2 P34913 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ CHRNB2 P17787 1/20 0.34
▸ CHRNB4 P30926 1/20 0.34
▸ CHRNA4 P43681 1/20 0.34
▸ BCHE P06276 3/20 0.33
▸ ACHE P22303 3/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ KDM5A P29375 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23730160 1.00 KDM4C (0.39) KDM4CPHF8KDM4AKDM2AEPHX2
SCHEMBL23730156 0.95 LMNA (0.38) KDM4CPHF8KDM4AKDM2AEPHX2
SCHEMBL26479835 0.86 KDM4C (0.44) KDM4CPHF8KDM4AKDM2AEPHX2
SCHEMBL21227661 0.85 EPHX2 (0.47) EPHX2ALDH1A1KMT2AMEN1LMNA
SCHEMBL22872799 0.85 EPHX2 (0.47) EPHX2ALDH1A1KMT2AMEN1LMNA
SCHEMBL23872567 0.83 KDM4C (0.54) KDM4CPHF8KDM4AKDM2AEPHX2
SCHEMBL21227763 0.83 KDM4C (0.54) KDM4CPHF8KDM4AKDM2AEPHX2
Hydrochloric Acid SCHEMBL10671346 0.81 ALDH1A1 (0.47) KDM4CPHF8EPHX2ALDH1A1KMT2A
SCHEMBL23730168 0.81 LMNA (0.41) KDM4CPHF8KDM4AKDM2AEPHX2
SCHEMBL22872800 0.81 KDM4C (0.51) KDM4CPHF8KDM4AKDM2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155321-A2 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2021-08-05 — — WO disclosed
Send feedback